William Ashton

William Ashton is a declared insider at 4 companies (board member); the most frequent names are Spectrum Pharmaceuticals Inc, Societal CDMO, Inc. and Baudax Bio, Inc. We count 30 filings; the first trade dates from 20 January 2017 and the latest from 8 April 2024.

The open-market side counts 1 purchase for €9,340 alongside 5 sales for €100k. Taken together, the sales exceed the purchases by €91k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 21 share grants and 1 option exercise.

The newest entry dates from 8 April 2024: a transaction of €192k, in Societal CDMO, Inc. The last insider purchase was made public on 28 August 2023, 1,151 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.